Showing results (71-80 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|June 17, 2024
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinomaLinfu Zhou, Yao Li, Diwei Zheng, et al.
Molecular Therapy. Oncology|May 15, 2024
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancerThai Q Tran, Jeff Grein, Mohammed Selman, et al.
Molecular Therapy. Oncology|December 1, 2025
Targeted degradation of KRAS and induction of bystander effects by a modular bioPROTACShojiro Inano, Akifumi Takaori-Kondo, Takako Nakajima
Molecular Therapy. Oncology|December 24, 2025
Using the iCasp9 suicide strategy to control the growth and function of genome-edited B cells with redirected antigen specificityJenny Léonard, Marine Cahen, Anne-Laure Tanguy, et al.
Molecular Therapy. Oncology|April 29, 2024
Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12Lei Wang, Xusha Zhou, Xiaoqing Chen, et al.
Molecular Therapy. Oncology|May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profilesKonstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Molecular Therapy. Oncology|June 15, 2026
Innovative photodynamic therapy using rose bengal for the treatment of human melanomaMarie Boileau, Anthony Lefebvre, Smail Marhfor, et al.
Molecular Therapy. Oncology|June 30, 2026
Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BCGabriella Antignani, Michaela Feodoroff, Jacopo Chiaro, et al.
Molecular Therapy. Oncology|July 1, 2026
Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicityFrederic St-Denis-Bissonnette, Karan Mediratta, Nicholas Ho, et al.
Molecular Therapy. Oncology|July 13, 2026
Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasisZhifang Zhang, Annie Yang, Anthony K Park, et al.
Pageof 41